Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Neoplasms, Second Primary 1Leukemia, Biphenotypic, Acute 1Congenital Abnormalities 1Carcinoma, Renal Cell 1Asymptomatic Brain Metastases 1

Interventions

Cytarabine 14Cyclophosphamide 12Whole-Body Irradiation 10Methotrexate 9venetoclax 8fludarabine 7Vincristine 7Specimen Handling 7Mycophenolic Acid 7Dexamethasone 7fludarabine phosphate 6Idarubicin 5Hydrocortisone 5Daunorubicin 5Calcium Dobesilate 5Biopsy 5Azacitidine 5revumenib 4calaspargase pegol 4blinatumomab 4X-Rays 4Stem Cell Transplantation 4Peripheral Blood Stem Cell Transplantation 4Mercaptopurine 4Filgrastim 4Cyclosporins 4Cyclosporine 4Cladribine 4pegylated granulocyte colony-stimulating factor 3dexamethasone acetate 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Leukemia, Biphenotypic, Acute × Tyrosine Kinase Inhibitors × Clear all
NCT04440267 2025-08-06

Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Recruiting
50 enrolled
Other hematologic neoplasm

Leukemia, Biphenotypic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡